P&G Health Posts Strong Sales Growth Amid Rising Demand for Vitamins and Supplements

Procter & Gamble Health (P&G Health) reported a 7% year-on-year increase in sales to Rs 356 crore for the quarter ended June 30, 2026. The company's profit after tax (PAT) surged 45% to Rs 96 crore.

The growth was driven by resilient consumer demand and stronger retail execution. Excluding one-time proceeds from the sale of an immovable asset, operational PAT stood at Rs 72 crore, marking a 9% increase over the corresponding quarter last year.

Managing Director Milind Thatte said the company had entered FY27 with strong momentum, supported by science-backed product innovations and investments in its distribution and supply chain network. The results come as parent company Procter & Gamble steps up its global healthcare ambitions, with a recent acquisition of wellness brand Thorne.